A Study of Cetuximab Plus Raltitrexed for Maintenance Treatment in Advanced Colorectal Cancer
Status:
Recruiting
Trial end date:
2021-11-28
Target enrollment:
Participant gender:
Summary
Maintenance treatment can extend patient survival and improve patient quality of life.
Bevacizumab alone or capecitabine combined with bevacizumab as a maintenance treatment have
been widely used in clinical practice. In contrast, there are little datas of cetuximab as a
maintenance treatment. The purpose of this study is to evaluate efficacy and safety of
Raltitrexed plus Cetuximab as the maintenance treatment, and to provide a new choice for RAS
wild-type colorectal cancer patients after advanced first-line chemotherapy.